An Affordable and Efficient In-House Approach for Detecting Gene Fusions in Bone and Soft Tissue Tumors Using a

Yoji Kukita1, Ken-Ichi Yoshida2, Satoshi Takenaka3

  • 1Laboratory of Genomic Pathology, Next-Generation Precision Cancer Research Center, Osaka International Cancer Institute, Osaka, Japan.

Summary

We developed a cost-effective in-house workflow for detecting gene fusions in rare cancers using nanopore sequencing. This method accurately identifies full-length transcripts in various sample types, improving molecular diagnostics accessibility.

Related Concept Videos